Vor Biopharma Inc.
VOR- Exchange
- Nasdaq
- Industry
- Biological Products, (No Diagnostic Substances)
- SEC CIK
- 0001817229
In the last 90 days, Vor Biopharma Inc. insiders filed 0 open-market purchases and 1 sale; 102 institutions reported holding it in 13F filings for Q2 2026, worth $893.0M in total; no superinvestor holds it.
Q2 2026 vs. Q1 2026
How the institutions holding Vor Biopharma Inc. changed between Q1 2026 and Q2 2026.
All holders in Q2 2026All holders in Q1 2026
| Measure | Q1 2026 | Q2 2026 | Change |
|---|---|---|---|
| Holders | 80 | 102 | +22 |
| Shares | 40.4M | 48.5M | +8.06M (+19.9%) |
| Value | $716.9M | $893.0M | +$176.2M (+24.6%) |
New holders (39)
Institutions that held Vor Biopharma Inc. at the end of Q2 2026 but not at the end of Q1 2026.
Sold out (17)
Institutions that held Vor Biopharma Inc. at the end of Q1 2026 and filed for Q2 2026 without it.
| Institution | Shares, Q1 2026 | Value, Q1 2026 |
|---|---|---|
| Laurion Capital Management LP | 318,670 | $5.69M |
| Propel Bio Management, LLC | 314,543 | $5.59M |
| Quadrature Capital Ltd | 76,630 | $1.37M |
| Jane Street Group, LLC | 75,890 | $1.35M |
| Simplify Asset Management Inc. | 53,510 | $954.6K |
| Brevan Howard Capital Management LP | 42,217 | $753.2K |
| Irenic Capital Management LP | 32,663 | $582.7K |
| Bollard Group LLC | 23,987 | $428.0K |
| Axq Capital, LP | 15,019 | $267.9K |
| Independent Financial Group, LLC | 13,975 | $249.3K |
| Winton Group Ltd | 11,870 | $211.8K |
| Cannon Global Investment Management, LLC | 11,700 | $208.7K |
| Diametric Capital, LP | 10,070 | $179.6K |
| Quantbot Technologies LP | 307 | $5.48K |
| MAI Capital Management | 40 | $714 |
| Ameritas Advisory Services, LLC | 37 | $660 |
| Fortitude Family Office, LLC | 31 | $553 |